JOURNAL ARTICLE
Add like
Add dislike
Add to saved papers

"Latent lupus".

Twenty-two patients with constellation of features suggestive of systemic lupus erythematosus (SLE), but who did not qualify by "criteria" or a rheumatologist's intuition as having SLE, have been followed prospectively for at least 5 years, and have been labeled latent lupus. These patients presented with at least one of the 1971 or 1982 classification criteria, plus any of a constellation of minor criteria. They differed from patients with SLE in the absence of renal and central nervous system disease, and the lower frequency of DNA antibodies and depressed complement. They had a similar distribution of HLA antigens. Seven of the 22 patients evolved into SLE during the period of followup. There were no clinical or laboratory features which distinguished these patients from the remaining 15 with persistent latent lupus. Patients with latent lupus may represent a mild spectrum of SLE, and evolutionary phase of classic SLE, or a diathesis awaiting other provoking factors.

Full text links

For the best experience, use the Read mobile app

Group 7SearchHeart failure treatmentPapersTopicsCollectionsEffects of Sodium-Glucose Cotransporter 2 Inhibitors for the Treatment of Patients With Heart Failure Importance: Only 1 class of glucose-lowering agents-sodium-glucose cotransporter 2 (SGLT2) inhibitors-has been reported to decrease the risk of cardiovascular events primarily by reducingSeptember 1, 2017: JAMA CardiologyAssociations of albuminuria in patients with chronic heart failure: findings in the ALiskiren Observation of heart Failure Treatment study.CONCLUSIONS: Increased UACR is common in patients with heart failure, including non-diabetics. Urinary albumin creatininineJul, 2011: European Journal of Heart FailureRandomized Controlled TrialEffects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial.Review

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

Read by QxMD is copyright © 2021 QxMD Software Inc. All rights reserved. By using this service, you agree to our terms of use and privacy policy.

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app